Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
50
AFYA Quote, Financials, Valuation and Earnings
Last price:
$14.66
Seasonality move
:
-4.23%
Day range:
$14.13 - $14.97
52-week range:
$13.47 - $19.90
Dividend yield:
1.58%
P/E ratio:
10.70x
P/S ratio:
2.13x
P/B ratio:
1.49x
Volume:
107.3K
Avg. volume:
90.9K
1-year change:
-5.16%
Market cap:
$1.3B
Revenue:
$612.9M
EPS (TTM):
$1.37
Analysts' Opinion
-
Consensus RatingAfya Ltd. has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 2 Hold ratings, and 2 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $18.95, Afya Ltd. has an estimated upside of 26.37% from its current price of $14.81.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $15.95 representing 100% downside risk from its current price of $14.81.
Fair Value
-
According to the consensus of 6 analysts, Afya Ltd. has 26.37% upside to fair value with a price target of $18.95 per share.
AFYA vs. S&P 500
-
Over the past 5 trading days, Afya Ltd. has underperformed the S&P 500 by -0.94% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Afya Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Afya Ltd. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Afya Ltd. reported revenues of $170.4M.
Earnings Growth
-
Afya Ltd. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Afya Ltd. reported earnings per share of $0.31.
Enterprise value:
1.7B
EV / Invested capital:
1.17x
Price / LTM sales:
2.13x
EV / EBIT:
8.15x
EV / Revenue:
2.68x
PEG ratio (5yr expected):
0.82x
EV / Free cash flow:
12.29x
Price / Operating cash flow:
9.75x
Enterprise value / EBITDA:
6.24x
Gross Profit (TTM):
$414.4M
Return On Assets:
8.14%
Net Income Margin (TTM):
20.49%
Return On Equity:
16.42%
Return On Invested Capital:
9.65%
Operating Margin:
30.62%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $540M | $616.7M | $638.2M | $151.7M | $170.4M | |
| Gross Profit | $330.8M | $385M | $414.4M | $93.2M | $108M | |
| Operating Income | $144.4M | $179.8M | $210M | $42.8M | $52.2M | |
| EBITDA | $197.3M | $243M | $274.2M | $58.2M | $69.6M | |
| Diluted EPS | $0.77 | $1.21 | $1.37 | $0.24 | $0.31 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $263.1M | $224.4M | $284.2M | $271.1M | $330.9M | |
| Total Assets | $1.2B | $1.2B | $1.6B | $1.6B | $1.7B | |
| Current Liabilities | $121M | $180.6M | $241.1M | $169.9M | $338M | |
| Total Liabilities | $630M | $663.2M | $855.5M | $837.7M | $826.3M | |
| Total Equity | $560.5M | $586.8M | $709.1M | $762.4M | $898.8M | |
| Total Debt | $390.3M | $364.4M | $517.7M | $567.4M | $386.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $210.1M | $200M | $197.8M | $79M | $77.4M | |
| Cash From Investing | -$220M | -$216.2M | -$88M | -$109M | -$27.7M | |
| Cash From Financing | $26.4M | $15.3M | -$83.6M | $50M | -$67M | |
| Free Cash Flow | $157.5M | $125.1M | $139.3M | $48.2M | $61.7M | |
AFYA
Sector
Market Cap
$1.3B
$324.3M
Price % of 52-Week High
73.67%
73.3%
Dividend Yield
1.58%
0%
Shareholder Yield
-1.23%
1.97%
1-Year Price Total Return
-5.16%
-3.66%
Beta (5-Year)
0.516
0.537
Dividend yield:
1.58%
Annualized payout:
$0.00
Payout ratio:
-19.72%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$14.59
200-day SMA
Sell
Level
$16.25
Bollinger Bands (100)
Sell
Level
14.4 - 15.44
Chaikin Money Flow
Buy
Level
2.5M
20-day SMA
Buy
Level
$14.75
Relative Strength Index (RSI14)
Buy
Level
53.62
ADX Line
Sell
Level
13.74
Williams %R
Neutral
Level
-55.7692
50-day SMA
Buy
Level
$14.64
MACD (12, 26)
Sell
Level
-0.03
25-day Aroon Oscillator
Sell
Level
-48
On Balance Volume
Neutral
Level
9.5M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.4361)
Buy
CA Score
(Annual)
Level (0.1884)
Buy
Beneish M-Score
(Annual)
Level (-2.9419)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.2537)
Buy
Piotroski F Score
(Annual)
Level (9)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Afya Ltd. is a medical education group, which engages in the provision of an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners through their medical residency preparation, post-graduate programs, and continuing medical education activities. It operates through Education Services; and Digital Content, Residency Preparatory and Specialization Programs segments. The Education Services segment provides educational services through undergraduate and graduate courses related to medicine, other health sciences, and other undergraduate programs. The Residency Preparatory and Specialization Programs segment offers digital and printed medical content services, including online courses for residency preparatory, medical and other than medical post-graduate specialization programs and mobile app subscription for digital medical content. The company was founded on March 22, 2019 and is headquartered in Nova Lima, Brazil.
Stock Forecast FAQ
In the current month, AFYA has received 2 Buy ratings 2 Hold ratings, and 2 Sell ratings. The AFYA average analyst price target in the past 3 months is $18.95.
-
Where Will Afya Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Afya Ltd. share price will rise to $18.95 per share over the next 12 months.
-
What Do Analysts Say About Afya Ltd.?
Analysts are divided on their view about Afya Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Afya Ltd. is a Sell and believe this share price will drop from its current level to $15.95.
-
What Is Afya Ltd.'s Price Target?
The price target for Afya Ltd. over the next 1-year time period is forecast to be $18.95 according to 6 Wall Street analysts, 2 of them rate the stock a Buy, 2 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is AFYA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Afya Ltd. is a Hold. 2 of 6 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of AFYA?
You can purchase shares of Afya Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Afya Ltd. shares.
-
What Is The Afya Ltd. Share Price Today?
Afya Ltd. was last trading at $14.66 per share. This represents the most recent stock quote for Afya Ltd.. Yesterday, Afya Ltd. closed at $14.81 per share.
-
How To Buy Afya Ltd. Stock Online?
In order to purchase Afya Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get AFYA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AFYA
Sector
P/E ratio
10.70x
17.37x
PEG ratio
0.82x
0.11x
P/B ratio
1.49x
1.33x
Price / LTM sales
2.13x
0.57x
Growth Metrics
AFYA
Sector
Revenue growth
12.35%
3.54%
Earnings growth
31.6%
--
Revenue (5-year growth)
26.36%
3.17%
Earnings forecast
$0.33
$0.25
Profitability
AFYA
Sector
Profitability FY 2024
$387.5M
$298.2M
Return on invested capital
9.65%
3.4%
Return on assets
8.14%
2.25%
Return on equity
16.42%
5.88%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Mar
12
Estimated Next Earnings Date
Feb
11
Balance Sheet
AFYA
Sector
Total cash
$187.2M
$130M
Short term investments
--
$41M
Total assets
$1.4B
$1.1B
Long term debt
$386.4M
$36M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
Sell
32
SMX alert for Dec 24
SMX (Security Matters) Plc [SMX] is down 8.94% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
